Keywords
Last Name
Institution

Linda M. Rolnitzky

TitleRESEARCH ASSISTANT
InstitutionMount Sinai
DepartmentPreventive Medicine
Address

     Bibliographic 
     selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Schussel J, Zhou XC, Zhang Z, Pattani K, Bermudez F, Jean-Charles G, McCaffrey T, Padhya T, Phelan J, Spivakovsky S, Brait M, Li R, Bowne HY, Goldberg JD, Rolnitzky L, Robbins M, Kerr AR, Sirois D, Califano JA. EDNRB and DCC salivary rinse hypermethylation has a similar performance as expert clinical examination in discrimination of oral cancer/dysplasia versus benign lesions. Clin Cancer Res. 2013 Jun 15; 19(12):3268-75.
      View in: PubMed
    2. Miller EA, Spadaccia MR, O'Brien MP, Rolnitzky L, Sabado R, Manches O, Frleta D, Bhardwaj N. Plasma factors during chronic HIV-1 infection impair IL-12 secretion by myeloid dendritic cells via a virus-independent pathway. J Acquir Immune Defic Syndr. 2012 Dec 15; 61(5):535-44.
      View in: PubMed
    3. Shah B, Danoff A, Radford MJ, Rolnitzky L, Sedlis SP. Periprocedural management of the patient with diabetes mellitus undergoing coronary angiography: current practice. Arch Intern Med. 2012 Oct 22; 172(19):1514-6.
      View in: PubMed
    4. Axelrod FB, Rolnitzky L, Gold von Simson G, Berlin D, Kaufmann H. A rating scale for the functional assessment of patients with familial dysautonomia (Riley Day syndrome). J Pediatr. 2012 Dec; 161(6):1160-5.
      View in: PubMed
    5. Safra T, Borgato L, Nicoletto MO, Rolnitzky L, Pelles-Avraham S, Geva R, Donach ME, Curtin J, Novetsky A, Grenader T, Lai WC, Gabizon A, Boyd L, Muggia F. BRCA mutation status and determinant of outcome in women with recurrent epithelial ovarian cancer treated with pegylated liposomal doxorubicin. Mol Cancer Ther. 2011 Oct; 10(10):2000-7.
      View in: PubMed
    6. Godefroy E, Manches O, Dréno B, Hochman T, Rolnitzky L, Labarrière N, Guilloux Y, Goldberg J, Jotereau F, Bhardwaj N. Matrix metalloproteinase-2 conditions human dendritic cells to prime inflammatory T(H)2 cells via an IL-12- and OX40L-dependent pathway. Cancer Cell. 2011 Mar 8; 19(3):333-46.
      View in: PubMed
    7. O'Brien M, Manches O, Sabado RL, Baranda SJ, Wang Y, Marie I, Rolnitzky L, Markowitz M, Margolis DM, Levy D, Bhardwaj N. Spatiotemporal trafficking of HIV in human plasmacytoid dendritic cells defines a persistently IFN-a-producing and partially matured phenotype. J Clin Invest. 2011 Mar; 121(3):1088-101.
      View in: PubMed
    8. Stern JD, Rolnitzky L, Goldberg JD, Chinitz LA, Holmes DS, Bernstein NE, Bernstein SA, Khairy P, Aizer A. Meta-analysis to assess the appropriate endpoint for slow pathway ablation of atrioventricular nodal reentrant tachycardia. Pacing Clin Electrophysiol. 2011 Mar; 34(3):269-77.
      View in: PubMed
    9. Reh A, Chaudhry S, Mendelsohn F, Im S, Rolnitzky L, Amarosa A, Levitz M, Srinivasa S, Krey L, Berkeley AS, Grifo JA, Danoff A. Effect of autoimmune thyroid disease in older euthyroid infertile woman during the first 35 days of an IVF cycle. Fertil Steril. 2011 Mar 1; 95(3):1178-81.
      View in: PubMed
    10. Brem H, Maggi J, Nierman D, Rolnitzky L, Bell D, Rennert R, Golinko M, Yan A, Lyder C, Vladeck B. High cost of stage IV pressure ulcers. Am J Surg. 2010 Oct; 200(4):473-7.
      View in: PubMed
    11. Pattani KM, Zhang Z, Demokan S, Glazer C, Loyo M, Goodman S, Sidransky D, Bermudez F, Jean-Charles G, McCaffrey T, Padhya T, Phelan J, Spivakovsky S, Bowne HY, Goldberg JD, Rolnitzky L, Robbins M, Kerr AR, Sirois D, Califano JA. Endothelin receptor type B gene promoter hypermethylation in salivary rinses is independently associated with risk of oral cavity cancer and premalignancy. Cancer Prev Res (Phila). 2010 Sep; 3(9):1093-103.
      View in: PubMed
    12. Sabbaghian MS, Rothberger G, Alongi AP, Gagner JP, Goldberg JD, Rolnitzky L, Chiriboga L, Hajdu CH, Zagzag D, Basch R, Shamamian P. Levels of elevated circulating endothelial cell decline after tumor resection in patients with pancreatic ductal adenocarcinoma. Anticancer Res. 2010 Jul; 30(7):2911-7.
      View in: PubMed
    13. Firoz EF, Warycha M, Zakrzewski J, Pollens D, Wang G, Shapiro R, Berman R, Pavlick A, Manga P, Ostrer H, Celebi JT, Kamino H, Darvishian F, Rolnitzky L, Goldberg JD, Osman I, Polsky D. Association of MDM2 SNP309, age of onset, and gender in cutaneous melanoma. Clin Cancer Res. 2009 Apr 1; 15(7):2573-80.
      View in: PubMed
    14. Laughon SK, Rebarber A, Rolnitzky L, Fink L, Saltzman DH. Decreased first-trimester maternal serum free-beta subunit human chorionic gonadotropin and preterm birth in twin gestations. Am J Perinatol. 2009 Aug; 26(7):491-4.
      View in: PubMed
    15. Gold-von Simson G, Goldberg JD, Rolnitzky LM, Mull J, Leyne M, Voustianiouk A, Slaugenhaupt SA, Axelrod FB. Kinetin in familial dysautonomia carriers: implications for a new therapeutic strategy targeting mRNA splicing. Pediatr Res. 2009 Mar; 65(3):341-6.
      View in: PubMed
    16. Gold-von Simson G, Leyne M, Mull J, Rolnitzky LM, Goldberg JD, Berlin D, Axelrod FB, Slaugenhaupt SA. IKBKAP mRNA in peripheral blood leukocytes: a molecular marker of gene expression and splicing in familial dysautonomia. Pediatr Res. 2008 Feb; 63(2):186-90.
      View in: PubMed
    17. MacDonald SM, Desai N, Heller G, Rolnitzky L, Allen JC. MRI changes in the "normal" pineal gland following chemotherapy for suprasellar germ cell tumors. Pediatr Hematol Oncol. 2008 Jan-Feb; 25(1):5-15.
      View in: PubMed
    18. Ost D, Goldberg J, Rolnitzky L, Rom WN. Survival after surgery in stage IA and IB non-small cell lung cancer. Am J Respir Crit Care Med. 2008 Mar 1; 177(5):516-23.
      View in: PubMed
    19. Axelrod FB, Goldberg JD, Rolnitzky L, Mull J, Mann SP, Gold von Simson G, Berlin D, Slaugenhaupt SA. Fludrocortisone in patients with familial dysautonomia--assessing effect on clinical parameters and gene expression. Clin Auton Res. 2005 Aug; 15(4):284-91.
      View in: PubMed
    20. Brandwein-Gensler M, Teixeira MS, Lewis CM, Lee B, Rolnitzky L, Hille JJ, Genden E, Urken ML, Wang BY. Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival. Am J Surg Pathol. 2005 Feb; 29(2):167-78.
      View in: PubMed
    21. Wientgen H, Thorngate FE, Omerhodzic S, Rolnitzky L, Fallon JT, Williams DL, Fisher EA. Subphysiologic apolipoprotein E (ApoE) plasma levels inhibit neointimal formation after arterial injury in ApoE-deficient mice. Arterioscler Thromb Vasc Biol. 2004 Aug; 24(8):1460-5.
      View in: PubMed
    22. Berti LC, Zylbert S, Rolnitzky L. Comparison of health status of children using a school-based health center for comprehensive care. J Pediatr Health Care. 2001 Sep-Oct; 15(5):244-50.
      View in: PubMed
    23. Siqueira LM, Rolnitzky LM, Rickert VI. Smoking cessation in adolescents: the role of nicotine dependence, stress, and coping methods. Arch Pediatr Adolesc Med. 2001 Apr; 155(4):489-95.
      View in: PubMed
    24. Siqueira L, Diab M, Bodian C, Rolnitzky L. Adolescents becoming smokers: the roles of stress and coping methods. J Adolesc Health. 2000 Dec; 27(6):399-408.
      View in: PubMed
    25. Schmidt G, Malik M, Barthel P, Schneider R, Ulm K, Rolnitzky L, Camm AJ, Bigger JT, Schömig A. Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction. Lancet. 1999 Apr 24; 353(9162):1390-6.
      View in: PubMed
    26. Bigger JT, Parides MK, Rolnitzky LM, Meier P, Levin B, Egan DA. Changes in sample size and length of follow-up to maintain power in the coronary artery bypass graft (CABG) patch trial. Control Clin Trials. 1998 Feb; 19(1):1-14.
      View in: PubMed
    27. Bloomfield DM, Kaufman ES, Bigger JT, Fleiss J, Rolnitzky L, Steinman R. Passive head-up tilt and actively standing up produce similar overall changes in autonomic balance. Am Heart J. 1997 Aug; 134(2 Pt 1):316-20.
      View in: PubMed
    28. Bigger JT, Steinman RC, Rolnitzky LM, Fleiss JL, Albrecht P, Cohen RJ. Power law behavior of RR-interval variability in healthy middle-aged persons, patients with recent acute myocardial infarction, and patients with heart transplants. Circulation. 1996 Jun 15; 93(12):2142-51.
      View in: PubMed
    29. Bloomfield DM, Bigger JT, Pavri BB, Han J, Fleiss JL, Rolnitzky LM, Steinman RC. Vagal modulation of RR intervals during head-up tilt and the infusion of isoproterenol. Am J Cardiol. 1995 Jun 1; 75(16):1145-50.
      View in: PubMed
    30. Bigger JT, Fleiss JL, Steinman RC, Rolnitzky LM, Schneider WJ, Stein PK. RR variability in healthy, middle-aged persons compared with patients with chronic coronary heart disease or recent acute myocardial infarction. Circulation. 1995 Apr 1; 91(7):1936-43.
      View in: PubMed
    31. Bigger JT, Rolnitzky LM, Steinman RC, Fleiss JL. Predicting mortality after myocardial infarction from the response of RR variability to antiarrhythmic drug therapy. J Am Coll Cardiol. 1994 Mar 1; 23(3):733-40.
      View in: PubMed
    32. Bigger JT, Fleiss JL, Rolnitzky LM, Steinman RC. The ability of several short-term measures of RR variability to predict mortality after myocardial infarction. Circulation. 1993 Sep; 88(3):927-34.
      View in: PubMed
    33. Kaufman ES, Bosner MS, Bigger JT, Stein PK, Kleiger RE, Rolnitzky LM, Steinman RC, Fleiss JL. Effects of digoxin and enalapril on heart period variability and response to head-up tilt in normal subjects. Am J Cardiol. 1993 Jul 1; 72(1):95-9.
      View in: PubMed
    34. Bigger JT, Fleiss JL, Rolnitzky LM, Steinman RC. Frequency domain measures of heart period variability to assess risk late after myocardial infarction. J Am Coll Cardiol. 1993 Mar 1; 21(3):729-36.
      View in: PubMed
    35. Shea S, Bigger JT, Campion J, Fleiss JL, Rolnitzky LM, Schron E, Gorkin L, Handshaw K, Kinney MR, Branyon M. Enrollment in clinical trials: institutional factors affecting enrollment in the cardiac arrhythmia suppression trial (CAST). Control Clin Trials. 1992 Dec; 13(6):466-86.
      View in: PubMed
    36. Bigger JT, Fleiss JL, Steinman RC, Rolnitzky LM, Kleiger RE, Rottman JN. Correlations among time and frequency domain measures of heart period variability two weeks after acute myocardial infarction. Am J Cardiol. 1992 Apr 1; 69(9):891-8.
      View in: PubMed
    37. Bigger JT, Fleiss JL, Rolnitzky LM, Steinman RC. Stability over time of heart period variability in patients with previous myocardial infarction and ventricular arrhythmias. The CAPS and ESVEM investigators. Am J Cardiol. 1992 Mar 15; 69(8):718-23.
      View in: PubMed
    38. Fleiss JL, Bigger JT, Rolnitzky LM. The correlation between heart period variability and mean period length. Stat Med. 1992 Jan 15; 11(1):125-9.
      View in: PubMed
    39. Bigger JT, Fleiss JL, Steinman RC, Rolnitzky LM, Kleiger RE, Rottman JN. Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation. 1992 Jan; 85(1):164-71.
      View in: PubMed
    40. Bigger JT, Fleiss JL, Rolnitzky LM, Steinman RC, Schneider WJ. Time course of recovery of heart period variability after myocardial infarction. J Am Coll Cardiol. 1991 Dec; 18(7):1643-9.
      View in: PubMed
    41. Kleiger RE, Bigger JT, Bosner MS, Chung MK, Cook JR, Rolnitzky LM, Steinman R, Fleiss JL. Stability over time of variables measuring heart rate variability in normal subjects. Am J Cardiol. 1991 Sep 1; 68(6):626-30.
      View in: PubMed
    42. Cook JR, Bigger JT, Kleiger RE, Fleiss JL, Steinman RC, Rolnitzky LM. Effect of atenolol and diltiazem on heart period variability in normal persons. J Am Coll Cardiol. 1991 Feb; 17(2):480-4.
      View in: PubMed
    43. Rottman JN, Steinman RC, Albrecht P, Bigger JT, Rolnitzky LM, Fleiss JL. Efficient estimation of the heart period power spectrum suitable for physiologic or pharmacologic studies. Am J Cardiol. 1990 Dec 15; 66(20):1522-4.
      View in: PubMed
    44. Lichstein E, Hager WD, Gregory JJ, Fleiss JL, Rolnitzky LM, Bigger JT. Relation between beta-adrenergic blocker use, various correlates of left ventricular function and the chance of developing congestive heart failure. The Multicenter Diltiazem Post-Infarction Research Group. J Am Coll Cardiol. 1990 Nov; 16(6):1327-32.
      View in: PubMed
    45. Bigger JT, Hoover CA, Steinman RC, Rolnitzky LM, Fleiss JL. Autonomic nervous system activity during myocardial ischemia in man estimated by power spectral analysis of heart period variability. The Multicenter Study of Silent Myocardial Ischemia Investigators. Am J Cardiol. 1990 Aug 15; 66(4):497-8.
      View in: PubMed
    46. Bigger JT, Coromilas J, Rolnitzky LM, Fleiss JL, Kleiger RE. Effect of diltiazem on cardiac rate and rhythm after myocardial infarction. Multicenter Diltiazem Postinfarction Trial Investigators. Am J Cardiol. 1990 Mar 1; 65(9):539-46.
      View in: PubMed
    47. Fleiss JL, Bigger JT, McDermott M, Miller JP, Moon T, Moss AJ, Oakes D, Rolnitzky LM, Therneau TM. Nonfatal myocardial infarction is, by itself, an inappropriate end point in clinical trials in cardiology. Circulation. 1990 Feb; 81(2):684-5.
      View in: PubMed
    48. Bigger JT, La Rovere MT, Steinman RC, Fleiss JL, Rottman JN, Rolnitzky LM, Schwartz PJ. Comparison of baroreflex sensitivity and heart period variability after myocardial infarction. J Am Coll Cardiol. 1989 Nov 15; 14(6):1511-8.
      View in: PubMed
    49. Bigger JT, Albrecht P, Steinman RC, Rolnitzky LM, Fleiss JL, Cohen RJ. Comparison of time- and frequency domain-based measures of cardiac parasympathetic activity in Holter recordings after myocardial infarction. Am J Cardiol. 1989 Sep 1; 64(8):536-8.
      View in: PubMed
    50. Bigger JT, Kleiger RE, Fleiss JL, Rolnitzky LM, Steinman RC, Miller JP. Components of heart rate variability measured during healing of acute myocardial infarction. Am J Cardiol. 1988 Feb 1; 61(4):208-15.
      View in: PubMed
    51. Marcus FI, Cobb LA, Edwards JE, Kuller L, Moss AJ, Bigger JT, Fleiss JL, Rolnitzky L, Serokman R. Mechanism of death and prevalence of myocardial ischemic symptoms in the terminal event after acute myocardial infarction. Am J Cardiol. 1988 Jan 1; 61(1):8-15.
      View in: PubMed
    52. The mortality risk associated with digitalis treatment after myocardial infarction. Cardiovasc Drugs Ther. 1987 Aug; 1(2):125-32.
      View in: PubMed
    53. Bigger JT, Fleiss JL, Rolnitzky LM. Prevalence, characteristics and significance of ventricular tachycardia detected by 24-hour continuous electrocardiographic recordings in the late hospital phase of acute myocardial infarction. Am J Cardiol. 1986 Dec 1; 58(13):1151-60.
      View in: PubMed
    54. Fleiss JL, Bigger JT, Rolnitzky LM. Is catch-22 alive and well and living at NHLBI? Reactions to 'digitalis--a new controversy regarding an old drug'. Circulation. 1986 Jan; 73(1):19-20.
      View in: PubMed
    55. Bigger JT, Fleiss JL, Rolnitzky LM, Merab JP, Ferrick KJ. Effect of digitalis treatment on survival after acute myocardial infarction. Am J Cardiol. 1985 Mar 1; 55(6):623-30.
      View in: PubMed
    56. Bigger JT, Fleiss JL, Kleiger R, Miller JP, Rolnitzky LM. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation. 1984 Feb; 69(2):250-8.
      View in: PubMed
    57. Bigger JT, Coromilas J, Weld FM, Reiffel JA, Rolnitzky LM. Prognosis after recovery from acute myocardial infarction. Annu Rev Med. 1984; 35:127-47.
      View in: PubMed
    58. Reiffel JA, Gang E, Bigger JT, Livelli F, Rolnitzky L, Cramer M. Sinus node recovery time related to paced cycle length in normals and patients with sinoatrial dysfunction. Am Heart J. 1982 Oct; 104(4 Pt 1):746-52.
      View in: PubMed
    59. Livelli FD, Bigger JT, Reiffel JA, Gang ES, Patton JN, Noethling PM, Rolnitzky LM, Gliklich JI. Response to programmed ventricular stimulation: sensitivity, specificity and relation to heart disease. Am J Cardiol. 1982 Sep; 50(3):452-8.
      View in: PubMed
    60. Bigger JT, Weld FM, Rolnitzky LM. Which postinfarction ventricular arrhythmias should be treated? Am Heart J. 1982 Apr; 103(4 Pt 2):660-6.
      View in: PubMed
    61. Bigger JT, Weld FM, Rolnitzky LM. Prevalence, characteristics and significance of ventricular tachycardia (three or more complexes) detected with ambulatory electrocardiographic recording in the late hospital phase of acute myocardial infarction. Am J Cardiol. 1981 Nov; 48(5):815-23.
      View in: PubMed
    62. Weld FM, Chu KL, Bigger JT, Rolnitzky LM. Risk stratification with low-level exercise testing 2 weeks after acute myocardial infarction. Circulation. 1981 Aug; 64(2):306-14.
      View in: PubMed
    Rolnitzky's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts
    _
    Co-Authors
    _
    Similar People
    _
    Same Department
     
    Mount Sinai Profiles is managed by Conduits - The Institutes for Translational Sciences at Icahn School of Medicine, supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number UL1TR000067